Discover 1,664 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,664
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: New Brunswick NJ, New York NY, Newark DE, New Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase3, Recruiting
New
A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.
for
Melanoma (Skin Cancer)
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18 - 70+
Code: NCT07830225
Recruiting
A Mobile Health Intervention Among Hispanics
for
Cancer of Skin
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18 - 70+
Code: NCT05389332
Recruiting
Busulfan Sample Collection Study
for
Subjects Treated With Busulfan
Location: New Brunswick NJ
Sponsor: Saladax Biomedical, Inc.
Sex: All
Age: 0+
Code: NCT05711732
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: New Brunswick NJ, Livingston NJ, Long Branch NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04172532
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
for
Hormone Receptor-Positive Breast Cancer,
Location: New Brunswick NJ, Somerville NJ, Elizabeth NJ,
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT06518837
Phase2, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: New Brunswick NJ, Doylestown PA, Philadelphia PA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase2, Recruiting
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
for
Prostate Cancer
Location: New Brunswick NJ, New York NY, Ann Arbor MI, Madison WI
Sponsor: Genta Incorporated
Sex: Male
Age: 18+
Code: NCT01296243
Phase2, Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
for
Breast Cancer
Location: New Brunswick NJ, Hackensack NJ, Stony Brook NY,
Sponsor: Exact Sciences Corporation
Sex: All
Age: 18+
Code: NCT06401421
Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05735184
Phase1, Recruiting
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
for
Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma
Location: New Brunswick NJ, Providence RI
Sponsor: Brown University
Sex: All
Age: 18+
Code: NCT04792502
Phase2, Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: New Brunswick NJ, New York NY, Buffalo NY, Cleveland OH,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase3, Recruiting
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
for
Pancreatic Ductal Adenocarcinoma
Location: New Brunswick NJ, Livingston NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT05296421
Recruiting
Bright Ideas - CIN Feasibility Study
for
Acute Lymphoblastic Leukemia (ALL)
Location: New Brunswick NJ, Falls Church VA, Toronto,
Sponsor: The Hospital for Sick Children
Sex: All
Age: 4 - 18
Code: NCT04929899
Recruiting
Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy
for
Gastric Cancer
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT05491213
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: New Brunswick NJ, Meadowbrook PA, Philadelphia PA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: New Brunswick NJ, Livingston NJ, Toms River NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase2, Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT01042379
Phase2, Recruiting
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
for
NSCLC, Stage I
Location: New Brunswick NJ, Hershey PA, Richmond VA,